UHS·Universal Health Services, Inc.

Universal Health Services (UHS) is a prominent healthcare provider operating a network of acute care hospitals and behavioral health facilities, offering a broad spectrum of medical and specialized mental health services. The company also engages in commercial health insurance and management services, positioning itself as a comprehensive player within the Healthcare sector's Medical Care Facilities industry. UHS has a history dating back to 1978 and is headquartered in King of Prussia, Pennsylvania. In its most recent reported quarters, UHS demonstrated a pattern of exceeding analyst expectations for Earnings Per Share (EPS). For Q3 2025, EPS was $5.69 against an estimate of $4.95, and for Q2 2025, actual EPS was $5.35 compared to an estimate of $4.96. Revenue also showed an upward trend, with Q3 2025 revenue at $4.50 billion and Q2 2025 revenue at $4.28 billion. This indicates a period of accelerating revenue growth and consistent EPS beats in the latter half of the reported fiscal year. Historically, UHS has shown a strong trajectory of year-over-year revenue growth, often accompanied by EPS beats. For instance, Q4 2025 saw actual EPS of $5.88, surpassing the estimate of $5.96, and revenue of $4.49 billion. The company has a track record of beating analyst estimates for EPS in multiple recent quarters, suggesting operational efficiency and effective management. While revenue estimates were not consistently provided for all periods, the actual revenue figures indicate a generally positive growth trend. Recent analyst actions reflect a generally positive but nuanced outlook for UHS. Argus Research raised its price target to $200.00, signaling strong confidence, while Wall Street Zen upgraded the stock to a 'buy.' However, Guggenheim lowered its price target to $238 from $262, though it maintained a 'Buy' rating, indicating a recalibration of valuation expectations. These adjustments suggest that while the underlying business is viewed favorably, analysts are refining their price targets based on evolving market conditions and company performance. Looking ahead, investors will be keen to observe if UHS can maintain its trend of exceeding EPS estimates in upcoming quarters. Key will be management's commentary regarding the drivers of revenue growth and profitability, especially in light of the mixed analyst price target adjustments. Monitoring any further shifts in institutional ownership and analyst ratings will also be important for understanding market sentiment towards UHS.